NCT01153685View on ClinicalTrials.gov

Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 9, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Influenza

Interventions

BIOLOGICAL

Fluviral®

Intramuscular injection, one dose

Trial Locations (1)

J1H 1Z1

GSK Investigational Site, Sherbrooke

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01153685 - Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years | Biotech Hunter | Biotech Hunter